Ewa Olech

1.1k total citations
30 papers, 805 citations indexed

About

Ewa Olech is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Ewa Olech has authored 30 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 7 papers in Hematology and 7 papers in Immunology. Recurrent topics in Ewa Olech's work include Rheumatoid Arthritis Research and Therapies (23 papers), Systemic Lupus Erythematosus Research (8 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Ewa Olech is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (23 papers), Systemic Lupus Erythematosus Research (8 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Ewa Olech collaborates with scholars based in United States, United Kingdom and Switzerland. Ewa Olech's co-authors include Joan T. Merrill, Charles Peterfy, Julie C. DiCarlo, David E. Yocum, Norman Gaylis, Alan Kivitz, Michael Borofsky, John V. Crues, William F. C. Rigby and S. Radominski and has published in prestigious journals such as PLoS ONE, Pain and Annals of the Rheumatic Diseases.

In The Last Decade

Ewa Olech

28 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa Olech United States 17 529 240 172 119 89 30 805
Laura Durcan Ireland 15 778 1.5× 549 2.3× 129 0.8× 120 1.0× 111 1.2× 33 1.3k
Silje Watterdal Syversen Norway 17 715 1.4× 222 0.9× 114 0.7× 205 1.7× 71 0.8× 39 1.2k
Kaoru Takase Japan 17 604 1.1× 143 0.6× 184 1.1× 51 0.4× 78 0.9× 44 1.1k
Ingrid Strusberg Argentina 9 731 1.4× 232 1.0× 367 2.1× 107 0.9× 114 1.3× 26 988
Norman Gaylis United States 16 866 1.6× 285 1.2× 382 2.2× 131 1.1× 143 1.6× 35 1.2k
Sabrina Dadoun France 14 427 0.8× 105 0.4× 138 0.8× 81 0.7× 85 1.0× 29 766
Franz Woltering United States 12 453 0.9× 458 1.9× 314 1.8× 84 0.7× 63 0.7× 28 922
Hiroyuki Nara Japan 9 305 0.6× 158 0.7× 115 0.7× 79 0.7× 54 0.6× 23 519
Linda Carli Italy 16 716 1.4× 366 1.5× 80 0.5× 153 1.3× 228 2.6× 48 977
Mara Felicetti Italy 16 323 0.6× 175 0.7× 98 0.6× 23 0.2× 43 0.5× 53 742

Countries citing papers authored by Ewa Olech

Since Specialization
Citations

This map shows the geographic impact of Ewa Olech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Olech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Olech more than expected).

Fields of papers citing papers by Ewa Olech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Olech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Olech. The network helps show where Ewa Olech may publish in the future.

Co-authorship network of co-authors of Ewa Olech

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Olech. A scholar is included among the top collaborators of Ewa Olech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Olech. Ewa Olech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kivitz, Alan, Ewa Olech, Michael Borofsky, et al.. (2017). Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis. The Journal of Rheumatology. 45(4). 456–464. 15 indexed citations
2.
Kivitz, Alan, Thomas W. Wallace, Ewa Olech, et al.. (2016). Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study. Rheumatology and Therapy. 3(2). 291–304. 19 indexed citations
3.
Al‐Sabbagh, Ahmad, Ewa Olech, Joseph E. McClellan, & Carol F. Kirchhoff. (2016). Development of biosimilars. Seminars in Arthritis and Rheumatism. 45(5). S11–S18. 38 indexed citations
4.
Olech, Ewa. (2016). Biosimilars: Rationale and current regulatory landscape. Seminars in Arthritis and Rheumatism. 45(5). S1–S10. 42 indexed citations
5.
Troum, O., Ewa Olech, Mikkel Østergaard, et al.. (2015). Proceedings from The 8th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) Conference. Seminars in Arthritis and Rheumatism. 45(6). e17–e23.
6.
7.
Conaghan, Philip G., Charles Peterfy, Ewa Olech, et al.. (2014). The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy. Annals of the Rheumatic Diseases. 73(5). 810–816. 43 indexed citations
8.
Emery, Paul, William F. C. Rigby, Paul P. Tak, et al.. (2014). Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program. PLoS ONE. 9(2). e87379–e87379. 64 indexed citations
9.
Conaghan, Philip G., Mikkel Østergaard, Maria Antonietta D’Agostino, et al.. (2013). Proceedings from the 5th Annual International Society for Musculoskeletal Imaging in Rheumatology Annual Conference. Seminars in Arthritis and Rheumatism. 42(4). 433–446. 1 indexed citations
10.
Rigby, William F. C., et al.. (2013). Safety of Rituximab in Combination with Other Biologic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: An Open-label Study. The Journal of Rheumatology. 40(5). 599–604. 23 indexed citations
11.
Rhudy, Jamie L., Jennifer L. DelVentura, Ellen L. Terry, et al.. (2013). Emotional modulation of pain and spinal nociception in fibromyalgia. Pain. 154(7). 1045–1056. 60 indexed citations
12.
Stohl, William, Juan J. Gómez‐Reino, Ewa Olech, et al.. (2012). Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial. Annals of the Rheumatic Diseases. 71(8). 1289–1296. 39 indexed citations
13.
Peterfy, Charles, et al.. (2012). Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI. Arthritis Research & Therapy. 14(3). R131–R131. 34 indexed citations
14.
Troum, O., et al.. (2012). Magnetic Resonance Imaging Applications in Early Rheumatoid Arthritis Diagnosis and Management. Rheumatic Disease Clinics of North America. 38(2). 277–297. 5 indexed citations
15.
Peterfy, Charles, P.J. Countryman, Annarita Gabriele, et al.. (2011). Magnetic Resonance Imaging in Rheumatoid Arthritis Clinical Trials: Emerging Patterns Based on Recent Experience. The Journal of Rheumatology. 38(9). 2023–2030. 17 indexed citations
16.
Olech, Ewa, et al.. (2009). Antiphospholipid antibodies in rheumatoid arthritis: Identifying the dominoes. Current Rheumatology Reports. 11(1). 43–51. 8 indexed citations
17.
Freeston, Jane, Ewa Olech, David E. Yocum, et al.. (2007). A modification of the Omeract RA MRI score for erosions for use with an extremity MRI system with reduced field of view. Annals of the Rheumatic Diseases. 66(12). 1669–1671. 6 indexed citations
18.
Furst, D E, Norman Gaylis, Ewa Olech, et al.. (2007). Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study. Annals of the Rheumatic Diseases. 66(7). 893–899. 88 indexed citations
19.
Olech, Ewa & Joan T. Merrill. (2006). The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis. Current Rheumatology Reports. 8(2). 100–108. 35 indexed citations
20.
Olech, Ewa & JT Merrill. (2005). DHEA supplementation: the claims in perspective.. Cleveland Clinic Journal of Medicine. 72(11). 965–966. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Durcan Breakdown of academic impact, for papers by Silje Watterdal Syversen Breakdown of academic impact, for papers by Kaoru Takase Breakdown of academic impact, for papers by Ingrid Strusberg Breakdown of academic impact, for papers by Norman Gaylis Breakdown of academic impact, for papers by Sabrina Dadoun Breakdown of academic impact, for papers by Franz Woltering Breakdown of academic impact, for papers by Hiroyuki Nara Breakdown of academic impact, for papers by Linda Carli Breakdown of academic impact, for papers by Mara Felicetti
Rankless by CCL
2026